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OBJECTIVE—Lactation has been associated with reduced
maternal risk of type 2 diabetes, the metabolic syndrome, and
cardiovascular disease. We examined the relationship between
breastfeeding duration and maternal adipokines at 3 years post-
partum.
RESEARCH DESIGN AND METHODS—We used linear re-
gression to relate the duration of lactation to maternal leptin,
adiponectin, ghrelin, and peptide YY (PYY) at 3 years postpartum
among 570 participants with 3-year postpartum blood samples
(178 fasting), prospectively collected lactation history, and no in-
tervening pregnancy in Project Viva, a cohort study of mothers
and children.
RESULTS—A total of 88% of mothers had initiated breastfeed-
ing, 26% had breastfed $12 months, and 42% had exclusively
breastfed for $3 months. In multivariate analyses, we found that
duration of total breastfeeding was directly related to PYY and
ghrelin, and exclusive breastfeeding duration was directly related
to ghrelin (predicted mean for never exclusively breastfeeding:
790.6 pg/mL vs. $6 months of exclusive breastfeeding: 1,008.1 pg/mL;
P , 0.01) at 3 years postpartum, adjusting for pregravid BMI,
gestational weight gain, family history of diabetes, parity, smok-
ing status, and age. We found a nonlinear pattern of association
between exclusive breastfeeding duration and adiponectin in
multivariate-adjusted models.
CONCLUSIONS—In this prospective cohort study, we found a
direct relationship between the duration of lactation and both ghrelin
and PYY at 3 years postpartum. Diabetes 60:1277–1285, 2011
T
ype 2 diabetes causes substantial morbidity and
mortality, affecting .9 million women in the U.S.
Recent epidemiologic data (1–4) suggest that
lactation may reduce a woman’s risk for this
disease. Lactation also has been associated with more fa-
vorable lipid proﬁles after weaning (5), reduced metabolic
syndrome risk (6,7), and lower rates of hypertension (3,8)
and myocardial infarction (3,9).
These ﬁndings suggest that lactation may be a modiﬁ-
able risk factor for metabolic disease in women. We have
previously hypothesized that lactation mobilizes maternal
adipose stores, resetting maternal metabolism after preg-
nancy (10). Adipose tissue produces cytokines called adi-
pokines, and these endocrine markers are associated with
subsequent metabolic disease risk. High leptin levels are
associated with adverse metabolic proﬁles (11,12), although
these associations are attenuated with adjustment for fat
mass. High ghrelin (13–16) and adiponectin (17–20) levels
are associated with reduced diabetes and metabolic dis-
ease risk. The protein peptide YY (PYY) also plays a key
role in metabolism and appetite regulation, and low PYY
levels are associated with obesity (21,22). No studies, to
our knowledge, have measured the association between
lactation and maternal levels of leptin, adiponectin, ghre-
lin, or PYY after weaning. We therefore examined the as-
sociation between lactation duration and these markers at
3 years postpartum in Project Viva, a prospective cohort
study of maternal and infant health. We hypothesized that
longer durations of lactation would be associated with
lower leptin and higher adiponectin, ghrelin, and PYY.
RESEARCH DESIGN AND METHODS
Women were recruited for Project Viva at their ﬁrst prenatal visit at one of eight
urban and suburban obstetrical ofﬁces of a multispecialty group practice in
eastern Massachusetts. To be eligible for the study, potential participants were
required to be ﬂuent in English, ,22 weeks’ gestation, and have a singleton
pregnancy; 65% of eligible women were recruited. All participants provided
written informed consent. The human studies committee of Harvard Pilgrim
Health Care approved all procedures in accordance with ethical standards for
human experimentation.
Of 2,128 participating women who gave birth, 1,579 were invited to a 3-year
follow-up examination because they had completed dietary questionnaires
during pregnancy; 761 of these women were eligible for the current analysis
because they had not delivered another child since the birth of the index child
3yearspreviously,theydidnothavetype1ortype2diabetes,andtheyattended
the 3-year visit. Of these women, 611 provided a blood sample. We excluded
women missing breastfeeding duration (n = 30), gestational weight gain (n =
4), gestational diabetes (n = 4), or adipokine measurements (n = 3), leaving
570 women for analysis. Fasting blood samples were available for 175 of 570
women.
When we compared women who provided fasting samples with those who
provided nonfasting samples, we found no differences in adiponectin, leptin,
breastfeeding duration, prepregnancy BMI, gestational weight gain, age, race,
parity, gestational glucose tolerance, or family history of diabetes. We excluded
from our exclusive lactation analysis women missing data on the timing of
introduction of formula or complementary foods (n = 130).
Assessment of lactation. At approximately 28 weeks’ gestation, study par-
ticipants provided information on their intention to breastfeed. Shortly after
delivery, participants again reported their intention and initiation of breast-
feeding. At the 6-month follow-up visit, we asked women whether they were
breastfeeding and whether they had introduced formula or solid foods.
Women reported timing of weaning and introduction of supplemental foods
in months, weeks, or days. We similarly assessed breastfeeding at 12 months
postpartum.
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ORIGINAL ARTICLEFor our categorical analysis, we coded duration of lactation as 0, .0t o,3,
$3t o,6, $ 6t o,12, and $ 12 months. We deﬁned exclusive lactation as
time to ﬁrst introduction of solid foods, formula, or juice. We coded duration
of exclusive lactation in the categories of 0, .0t o,1, 1 to ,3, 3 to ,6, and $6
months.
We used data on duration of breastfeeding, reasons for weaning or sup-
plementing, and mothers’ planned duration reported at 28 weeks’ gestation
to deﬁne “curtailed breastfeeding” as 1) weaning before 3 months among
mothers who planned to breastfeed at 3 months or 2) introduction of formula
before 3 months among mothers who planned to exclusively breastfeed at
3 months. We reasoned that the curtailed breastfeeding group may have had
physiologic lactation failures that did not affect women who had planned to
wean before 3 months. At the 6-month interview, mothers who were not ex-
clusively breastfeeding identiﬁed reasons for introducing formula from
a structured list. We classiﬁed women as having problems with milk supply if
they endorsed any of the following: “I wasn’t producing enough breast milk to
satisfy my baby,”“ I had difﬁculty or didn’t like pumping breast milk,” or
“My baby was not gaining enough weight with breastfeeding.” We used cate-
gories of never breastfeeding, curtailed breastfeeding with low milk supply,
curtailed breastfeeding without low milk supply, and successful breastfeeding
to assess whether low milk production was associated with maternal adipo-
kine levels at 3 years postpartum.
Assessment of adipokines at 3 years postpartum. Women returned with
their children at 3 years postpartum for a physical examination that included
anthropometricmeasurementsandabloodsample.Wetestedallbloodsamples
for leptin and adiponectin. We identiﬁed as fasting those participants who did
not eat or drink anything other than water for 8 h before blood samples were
obtained. We tested fasting blood samples for ghrelin and PYY. Blood samples
were collected by trained phlebotomists and transferred within 24 h for storage
in liquid-nitrogen freezers. Leptin (intra-assay coefﬁcient of variation [CV] 3.0–
3.3%, interassay CV 3.5–5.4%, and sensitivity 7.8 pg/mL) and adiponectin (intra-
assay CV 2.5–4.7%, interassay CV 5.8–6.9%, and sensitivity 0.89 ng/mL) were
measured by enzyme-linked immunosorbent assay (R&D Systems, Minneap-
olis, MN). Total ghrelin (acylated and deacylated) was measured by a radio-
immunoassay (Linco Research, St. Louis, MO) (intra-assay CV 3.3–10%,
interassay CV 14.7–17.8%, and sensitivity 93 pg/mL). PYY was measured using
an enzyme-linked immunosorbent assay (Diagnostic Systems Laboratory,
Webster, TX) with a sensitivity of 2.1 pg/mL, an intra-assay CV of 3.0%, an
interassay CV of 7.4%, and 100% cross-reactivity for the full-length peptide
(PYY1–36) and the truncated PYY3–36, both of which have biological activity.
Study covariates. At the initial prenatal visit, participants reported socio-
demographic variables, including parity, prepregnancy weight and height, and
family history of type 2 diabetes. We calculated gestational weight gain as the
difference between the last clinical weight recorded prior to delivery and the
self-reported prepregnancy weight. Self-reported prepregnancy weight in study
participants is highly correlated (r = 0.99) with clinically recorded prepregnant
weight (23). Maternal gestational glucose tolerance was assessed clinically
with the nonfasting 50-g oral glucose loading test (GLT) administered at 26–28
weeks’ gestation. Women with a result of $140 mg/dL underwent a 100-g oral
glucose tolerance test (OGTT), administered after an overnight fast. Normal
results were deﬁned by Carpenter-Coustan criteria (fasting ,95 mg/dL,
1h,180 mg/dL, 2 h ,155 mg/dL, and 3 h ,140 mg/dL). Gestational glucose
tolerance was categorized as normal (GLT ,140), transient hyperglycemia
(GLT $140, GTT with no abnormal results), impaired glucose tolerance (GTT
with one abnormal result), or gestational diabetes (GLT $140, GTT with two
or more abnormal results). Women returned with their children at 3 years
postpartum for a physical examination that included measured weight to the
nearest 0.1 kg using a research-quality scale. Weight change related to preg-
nancy was calculated as the difference between the 3-year physical exam
weight and self-reported prepregnancy weight. Hormonal contraceptive use
since the index birth was assessed at the 6-year visit (missing for n = 210).
Data analysis. We used Spearman correlation to measure associations among
adipokines. Prior to regression analysis, we log transformed PYY measure-
ments because this variable was not normally distributed. To facilitate in-
terpretation of both the magnitude and clinical signiﬁcance of differences
among lactation duration groups, we present results from our linear regression
models as predicted values and 95% CIs for participants of average BMI who
were white, aged 35–40 years, had two children, had no parental history of
type 2 diabetes, had normal glucose tolerance, were nonsmokers, and gained
15 kg during the index pregnancy. For PYY, we present predicted geometric
means and 95% CIs after exponentiation.
We used linear regression to model the relation between both total and
exclusive lactation duration category and adipokines at 3 years. We used the
partial F test to assess the signiﬁcance of differences among lactation duration
categories in predicting metabolic outcome. We included in our multivariate
models those covariates that were associated with duration of breastfeeding
or that were a priori risk factors for an adverse metabolic proﬁle at 3 years
postpartum. Smoking has been associated with differences in leptin and
ghrelin levels (24,25), and we therefore included current smoking status in our
multivariate-adjusted models. Because prepregnancy BMI had a nonlinear
association with breastfeeding duration, we used a three-knot quadratic spline
model (26) to adjust for prepregnancy BMI. Quadratic splines allow for more
complete adjustment for potential confounders than a linear or categorical
approach. In our multivariate models, we also adjusted for maternal age, race,
parity, gestational weight gain, gestational glucose tolerance (normal, tran-
sient hyperglycemia, impaired glucose tolerance, or gestational diabetes),
family history of type 2 diabetes, and smoking status. In our models of ex-
clusive duration, we further adjusted for duration of breastfeeding after
introduction of formula or complementary foods. For women who are ex-
clusively breastfeeding, the metabolic load of lactation may offset increased
caloric intake, whereas for women who are partially breastfeeding, increased
appetite may not be offset by caloric needs of breastfeeding. Thus, the net
effect of breastfeeding on metabolism may be different for a woman who
breastfeeds exclusively for 6 months and then weans completely compared
with a woman who breastfeeds exclusively for 6 months and then continues to
breastfeed partially.
We also used linear regression to quantify the association between adipo-
kines and continuously measured duration of total and exclusive breastfeeding.
To allow for nonlinear associations, we tested three models: linear duration;
linear duration plus duration squared; and duration modeled with a three-knot
quadratic spline. We used the likelihood ratio test to determine whether the
more complex approaches improved the ﬁt of the model, retaining the more
complex model for likelihood ratio test P , 0.05. We present graphs of the
model with the best ﬁt for each adipokine to facilitate interpretation. To de-
termine whether maternal BMI mediates the observed associations, we further
adjusted for BMI at 3 years postpartum.
To test whether hormonal contraception use confounded observed asso-
ciations, we further adjusted for 3-year postpartum use or nonuse among
women for whom this data were available (n = 360 for the full cohort and n =
121 for fasting outcomes). Hormonal contraception use did not alter the ob-
served associations, and it was therefore excluded from our analyses.
Both obesity and diabetes are risk factors for delayed lactogenesis and early
weaning, so curtailed lactation may be a marker for an adverse metabolic
proﬁle. We therefore hypothesized that early weaningwould beassociated with
higher leptin and lower adiponectin, PYY, and ghrelin levels. To test this hy-
pothesis, we compared adipokine levels among mothers in four categories:
1) those who had never breastfed; 2) those who breastfed for shorter than
they had planned and identiﬁed low milk supply as a reason for weaning or
supplementing; 3) those who breastfed for shorter than they had planned but
did not identify milk supply problems as a reason for weaning or supple-
menting; and 4) those who breastfed at least as long as they intended.
RESULTS
Breastfeeding was common in our cohort, with 88%
reporting having ever breastfed, 26% breastfeeding for $12
months, and 42% breastfeeding exclusively for $3 months.
Women who breastfed for $12 months were older and
were more likely to have three or more children and less
likely to be current smokers than those who breastfed for
shorter periods (Table 1). Prepregnancy BMI was lower
among women who would later initiate and sustain
breastfeeding: women who did not breastfeed had a means
(SD) BMI of 26.8 (6.0) kg/m
2, whereas those who would
breastfeed for $12 months had a mean BMI of 23.7 (3.8)
kg/m
2. Gestational weight gain, gestational glucose toler-
ance, and parental history of diabetes were not signiﬁ-
cantly associated with breastfeeding duration.
We found that leptin levels were inversely correlated
with adiponectin and ghrelin (Spearman r = 20.32 and
20.40, respectively; P , 0.0001). Ghrelin was directly as-
sociated with adiponectin (r = 0.16, P = 0.03) and with PYY
(r = 0.15, P = 0.047).
In unadjusted analyses, we found that longer breast-
feeding duration was associated with lower leptin and
higher ghrelin levels (Table 2). This association did not
persist after adjustment for prepregnancy BMI and other
risk factors (leptin: mean predicted value 7.6 ng/mL for
$12 months of lactation vs. 8.9 ng/mL for no lactation, P =
0.45; ghrelin: 810.5 pg/mL, for $12 months of lactation vs.
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sociation between duration category and adiponectin or
PYY.
When we measured the association between adipokine
levels and total breastfeeding duration modeled as a con-
tinuous variable, we found lower leptin and higher ghrelin
and PYY levels among women who had breastfed longer
in unadjusted models (Fig. 1A, E, and G). After adjustment
for prepregnancy BMI and other risk factors, this asso-
ciation persisted for ghrelin and PYY (Fig. 1F and H)
(ghrelin predicted mean: 749.5 for none vs. 852.9 pg/mL for
$12 months of breastfeeding, P = 0.05; PYY predicted
geometric mean: 55.0 for none vs. 63.4 pg/mL for $12
months of breastfeeding, P = 0.03). We found no associa-
tion with leptin in the multivariate models (Fig. 1B). We
found a nonlinear association between adiponectin and
duration of total breastfeeding in a multivariate-adjusted
three-knot quadratic spline model (Fig. 1D) (likelihood ratio
test, P =0 . 0 4 ) .
To determine whether breastfeeding intensity was as-
sociated with maternal metabolic markers at 3 years
postpartum, we compared adipokine levels among women
with different exclusive breastfeeding durations. In un-
adjusted models, we found higher leptin and lower ghrelin
levels among women who had never exclusively breastfed
(Table 3). When we adjusted for prepregnancy BMI and
other risk factors, we found that differences in ghrelin
levels were somewhat attenuated, but the association of
exclusive breastfeeding with leptin was strengthened
(leptin: multivariate adjusted mean predicted value for $6
TABLE 1
Baseline characteristics of study population by total duration of lactation. Data from 570 participants in Project Viva who presented
for follow-up at 3 years postpartum without an intervening birth
Months of lactation
P*
None .0t o,33 t o ,66 t o ,12 $12
n =7 0 n =9 2 n = 117 n = 141 n = 150
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Prepregnancy BMI (kg/m
2) 26.8 (6.0) 26.9 (7.3) 24.9 (5.0) 24.8 (5.2) 23.7 (3.8) ,0.001
Gestational weight gain (kg) 15.1 (6.7) 14.6 (6.2) 15.7 (5.5) 14.5 (5.2) 14.9 (5.0) 0.54
Postpartum weight retention at
3 years (kg) 3.7 (7.5) 1.8 (10.0) 2.9 (5.7) 2.4 (5.6) 1.8 (5.7) 0.28
Age at 3-year visit 36.0 (4.8) 36.8 (6.0) 37.2 (5.3) 38.2 (4.6) 38.8 (5.0) ,0.001
n (%) n (%) n (%) n (%) n (%)
Race 0.10
Asian 0 (0) 5 (5) 7 (6) 5 (4) 5 (3)
Black 12 (17) 16 (17) 21 (18) 13 (9) 19 (13)
Hispanic 2 (3) 9 (10) 11 (9) 8 (6) 7 (5)
Other 3 (4) 4 (4) 8 (7) 3 (2) 6 (4)
White 53 (76) 58 (63) 70 (60) 112 (79) 113 (75)
Parity 0.006
1 12 (17) 39 (42) 37 (32) 33 (23) 41 (27)
2 36 (51) 40 (44) 57 (49) 73 (52) 64 (43)
$3 22 (31) 13 (14) 23 (20) 35 (25) 45 (30)
Gestational glucose tolerance 0.74
Gestational diabetes 3 (4) 6 (7) 4 (3) 4 (3) 5 (3)
Impaired glucose tolerance 3 (4) 2 (2) 8 (7) 5 (4) 6 (4)
Transient hyperglycemia 5 (7) 12 (13) 13 (11) 14 (10) 11 (7)
Normal 59 (84) 72 (78) 92 (79) 118 (84) 128 (85)
Parental history of diabetes 0.85
Yes 11 (16) 17 (19) 19 (16) 20 (14) 20 (13)
No 59 (84) 75 (82) 98 (84) 121 (86) 130 (87)
Hormonal contraception† 0.04
Yes 4 (10) 16 (28) 7 (10) 17 (21) 16 (15)
No 37 (90) 42 (72) 64 (90) 65 (79) 92 (85)
Current smoker ,0.001
Yes 8 (11) 13 (14) 7 (6) 7 (5) 3 (2)
No 50 (71) 73 (79) 104 (89) 129 (91) 139 (93)
Missing 12 (17) 6 (7) 6 (5) 5 (4) 8 (5)
Plan to exclusively breastfeed
at 3 months ‡ ,0.001
Yes 1 (1) 12 (13) 26 (22) 74 (52) 100 (67)
No 69 (99) 80 (87) 91 (78) 67 (48) 50 (33)
Fasting sample 0.34
Yes 16 (23) 30 (33) 40 (34) 38 (27) 51 (34)
No 54 (77) 62 (67) 77 (66) 103 (73) 99 (66)
*ANOVA P value for continuous variables, x
2 P value for categorical variables. †Using hormonal contraception at 2–3 years postpartum, as
reported at the 6-year follow-up visit. Missing for 210 participants. ‡At the 28-week interview, each participant reported how she intended to
breastfeed her infant at 3 months postpartum.
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exclusive lactation, partial FP= 0.006). In the multivariate
model, an association of duration of exclusive lactation
with adiponectin levels became apparent. (adiponectin
multivariate-adjusted mean for $6 months 25.9 vs. 20.4 mg/mL
for no exclusive lactation, P = 0.05).
When we modeled duration of exclusive breastfeeding
as a continuous variable, we found that longer durations
were associated with lower leptin and higher ghrelin and
PYY levels in unadjusted models (Figs. 2A, E, and G). In
adjusted models, the direct association between duration
of exclusive breastfeeding and ghrelin persisted (Fig. 2F)
(predicted mean for never exclusively breastfeeding 790.6
vs. 1,008.1 pg/mL for $6 months of exclusive breastfeed-
ing, P , 0.01), but the associations between exclusive
breastfeeding and both PYY and leptin were no longer
present (Fig. 2B and H). We found evidence of a nonlinear
association between adiponectin and duration of exclusive
breastfeeding in our multivariate-adjusted, three-knot qua-
dratic spline model (Fig. 2D) (likelihood ratio test P =
0.03). Additional adjustment for maternal BMI at 3 years
postpartum did not materially alter any observed associa-
tions between total or exclusive breastfeeding and adipo-
kine levels.
To test our hypothesis that failed lactation would be
associated with higher leptin and lower ghrelin, adipo-
nectin, and PYY levels at 3 years postpartum, we created
a variable for curtailed lactation, either as a result of low
milk supply or issues not related to milk supply (Table 4).
In our multivariate-adjusted models, we found the lowest
leptin levels among women with a history of curtailed
lactation and low supply (predicted mean 6.8 ng/mL vs. 7.5
ng/mL for curtailed lactation without supply issues, 8.0 ng/mL
for successful breastfeeders, and 8.9 ng/mL for mothers
who did not breastfeed, partial F test P = 0.05; P for com-
parisons between curtailed breastfeeding with supply
problems versus both successful breastfeeding and never
breastfeeding ,0.05). Predicted mean levels of ghrelin
were highest among women who breastfed successfully
(824.4 pg/mL), followed by those with curtailed breast-
feeding and supply problems (774.0 pg/mL), those who
never breastfed (721.8 pg/mL), and curtailed breastfeeding
without supply problems (713.4 pg/mL). We did not ﬁnd
any pattern of association between curtailed versus suc-
cessful breastfeeding and adiponectin or PYY.
DISCUSSION
Consistent with our hypothesis, we found that long dura-
tion of both total and exclusive breastfeeding was asso-
ciated with higher maternal ghrelin and pancreatic PYY
levels at 3 years postpartum in a prospective cohort study,
independent of other risk factors for metabolic disease. In
contrast, we did not ﬁnd that breastfeeding duration was
independently associated with leptin levels, and there was
no linear association of lactation with adiponectin. We
further found no evidence that curtailed breastfeeding was
associated with an adverse adipokine proﬁle, suggesting
that physiologic difﬁculties with lactation that might result
in premature weaning are not themselves associated with
maternal adipokine proﬁle. This is the ﬁrst study, to our
knowledge, to measure the association between lactation
and adipokine levels after weaning. Our results provide
tentative evidence that longer lactation is associated with
favorable changes in appetite regulation pathways that
persist after weaning.
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LACTATION AND ADIPOKINES AFTER WEANING
1280 DIABETES, VOL. 60, APRIL 2011 diabetes.diabetesjournals.orgOur results conﬁrm and extend earlier work relating
breastfeeding to differences in maternal metabolic out-
comes after weaning. In large epidemiologic studies, we
and others have reported associations between longer
duration of lactation and reduced risk of diabetes (1–3),
hypertension (8), higher HDL cholesterol levels post-
weaning adjusted for preconception levels (5), metabolic
syndrome (6,7), and cardiovascular disease (3,9,27). The
mechanism underlying this association is unknown. Lac-
tation appears to mobilize adipose tissue accrued during
pregnancy, and we have previously hypothesized that
breastfeeding “resets” maternal metabolism after pregnancy,
reducing disease risk (10).
In this study, we did not ﬁnd any association between
lactation duration and maternal leptin levels, once we
adjusted for pregravid BMI. It is likely that unadjusted
FIG. 1. Total duration of breastfeeding and adipokine levels at 3 years postpartum. The graphs show predicted means and 95% CIs (unadjusted as well
as adjusted for pregravid BMI, race, age, parity, gestational weight gain and glucose tolerance, and parental history of type 2 diabetes) for a participant
with a prepregnancy BMI of 25.1 kg/m
2, the mean for the study population, modeled using a three-knot quadratic spline model for BMI. The participant
was a white woman, aged 35–40 years, has two children, has no parental history of diabetes, had normal glucose tolerance, is a nonsmoker, and gained
15 kg during the index pregnancy. P value is for likelihood ratio test for the presented model versus the model without breastfeeding duration.
A.M. STUEBE AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, APRIL 2011 1281associations between breastfeeding duration and leptin are
confounded by maternal BMI. We also found no consistent
association between lactation duration and adiponectin
levels. Because leptin and adiponectin are adipocyte
products, these results do not support the hypothesis that
changes in adipose tissue endocrinology mediate associa-
tions between breastfeeding and maternal metabolic out-
comes.
We found a modest direct association between breast-
feeding duration and levels of ghrelin and PYY, two gut-
secreted peptide hormones that regulate appetite through
reciprocal effects on hypothalamic orexogenic and an-
orexigenic pathways (28). In the fasting state, low PYY
levels and high ghrelin levels stimulate hunger, whereas
after feeding, PYY levels rise and ghrelin levels fall. Par-
doxically, low ghrelin levels are associated with obesity,
insulin resistance, hypertension, and type 2 diabetes in
cross-sectional studies (13,14,16). In a small study (n = 18)
of women at 4–5 weeks postpartum, Larson-Meyer et al.
(29) found slightly higher fasting levels of ghrelin in lac-
tating versus nonlactating mothers (971.8 [208.9] vs. 798.8
[271.8] pg/mL), but this difference was not statistically
signiﬁcant. PYY did not differ between lactating and non-
lactating women. Among ﬁve women in that study who
exclusively breastfed, ghrelin levels did not change from
baseline to 24 weeks postpartum, despite reductions in
total body fat and BMI (29). Ilcol et al. (30) measured
ghrelin concentrations during lactation in 16 women and
found increases in total ghrelin from 0–3t o4 –14 days
postpartum, followed by slightly lower but stable levels
from 15 to 30 days postpartum. The same authors mea-
sured total ghrelin in a cross-section sample of 159 women
and found stable levels from 15 to 180 days postpartum.
Rodent studies (31,32) provide conﬂicting evidence re-
garding ghrelin’s role in energy balance during lactation;
however, cows bred for milk production have higher
plasma ghrelin levels and greater energy intake during
lactation (33). It is possible that long-term lactation and
the associated negative energy balance induce changes in
fasting ghrelin levels that persist after weaning, reducing
the risk for metabolic disease. Alternately, women with
higher baseline ghrelin levels may produce more milk,
allowing them to continue breastfeeding longer. In this
case, long breastfeeding durations would be a marker for
reduced maternal metabolic risk.
Pancreatic PYY is an appetite-inhibiting peptide hor-
mone secreted by the intestine in response to a meal (22).
Obese individuals secrete less PYY than normal-weight
individuals, suggesting an impaired response to satiety
cues. Unlike the leptin resistance that can develop with
obesity, overweight individuals retain a normal appetite
response to infused PYY. We found a direct association
between the duration of lactation and fasting PYY levels.
This difference could improve energy balance, leading to
more weight loss or less weight gain among women with
longer durations of lactation. In support of this specula-
tion, we previously found that women in our cohort with
$6 months of exclusive breastfeeding had a lower BMI
and reduced pregnancy-associated weight retention at 3
years, compared with women who had never breastfed
exclusively (34).
When we measured the association between adipokine
levels and curtailed breastfeeding, we found lower leptin
and higher ghrelin levels among women who reported
problems with milk supply, compared with women with
curtailed breastfeeding who did not report supply
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LACTATION AND ADIPOKINES AFTER WEANING
1282 DIABETES, VOL. 60, APRIL 2011 diabetes.diabetesjournals.orgproblems. We acknowledge that we had only limited ability
to capture biologic versus cultural or social reasons for
weaning; however, our results do not support the hypothesis
that difﬁculty with milk production is a marker for an ad-
verse adipokine proﬁle.
No other studies to our knowledge have measured
associations between the duration of breastfeeding and
ghrelin or PYY levels after weaning; however, there is
tentative evidence that lactation is associated with long-term
changes in other hypothalamic neuroendocrine pathways.
During lactation, breastfeeding women have reduced
autonomic and adrenal responses to stressors, compared
with nonlactating postpartum control subjects (35–39).
Differences in hypothalamic-pituitary-adrenal activity may
FIG. 2. Duration of exclusive breastfeeding and adipokine levels at 3 years postpartum. The graphs show predicted means and 95% CIs (unadjusted
as well as adjusted for pregravid BMI, race, age, parity, gestational weight gain and glucose tolerance, and parental history of type 2 diabetes) for
a participant with a prepregnancy BMI of 25.1 kg/m
2, the mean for the study population, modeled using a three-knot quadratic spline model for
BMI. This participant continued to breastfeed for up to 3 months after introducing formula or solid foods, is a white woman aged 35–40 years, has
two children, has no parental history of diabetes, had normal glucose tolerance, is a nonsmoker, and gained 15 kg during the index pregnancy.
P value is for likelihood ratio test for the presented model versus the model without breastfeeding duration.
A.M. STUEBE AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 60, APRIL 2011 1283persist after weaning: Lankarani-Fard (40) measured fast-
ing cortisol levels among 749 postmenopausal women and
reported higher levels among women with .12 months of
lifetime lactation, compared with women with shorter
durations of breastfeeding. Coupled with our ﬁnding of
higher fasting ghrelin and PYY levels among women with
longer lactation, these results suggest that lactation may
have lasting effects on central neuroendocrine pathways.
Strengths of our study include its prospective assess-
ment of maternal BMI, metabolic disease risk factors, and
breastfeeding intention and duration; measurement of ex-
clusive breastfeeding; measurement of multiple adipokines
at 3 years; and our very high rate of breastfeeding initiation
and continuation. We also faced several limitations, in-
cluding the relatively small number of participants with
fasting blood samples, which may have limited our power
to detect subtle differences among duration categories. To
maximize our power, we therefore modeled associations
of adipokines with continuous as well as categorical mea-
sures of lactation duration.
Our study’s cross-sectional design also limits interpre-
tation of results. Without prepregnancy measures of met-
abolic markers, we cannot determine whether lactation
causes favorable changes in peptide hormone levels or
whether more favorable proﬁles predispose to successful
breastfeeding. Moreover, levels of measured adipokines
are correlated, and our ﬁndings for PYY and ghrelin likely
reﬂect interdependent mechanisms. In a cross-sectional,
observational study such as ours, we cannot determine
the causal direction of associations among adipokines.
Nevertheless, our study is the ﬁrst, to our knowledge, to
measure adipokines after weaning, and our results provide
evidence to support future, longitudinal studies. We also
had limited information on hormonal contraception use at
the time of the 3-year visit. However, adjustment for con-
traception among those for whom data were available did
not alter our results, reducing the likelihood that more
complete information would change our results. We also
did not measure fat mass at the time of blood sample
collection. Finally, false-positives are a concern, because
we measured four different adipokines and performed
multiple tests of association. However, our measures re-
ﬂect speciﬁc hypotheses regarding pathways that are not
independent, so statistical correction for multiple out-
comes would be overly conservative.
In conclusion, in a prospective study of maternal and
infant health, we found that longer duration of breastfeed-
ing was associated with higher maternal levels of ghrelin
and PYY at 3 years postpartum. These two gut peptides
regulate appetite and are associated with reduced risk of
metabolic disease. Our ﬁndings provide tentative evidence
that changes in hypothalamic appetite regulation may me-
diate associations between longer lactation and reduced
risk of maternal metabolic disease. Additional studies will
be needed to conﬁrm these ﬁndings in other populations
and to determine whether these associations are causal.
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TABLE 4
Adipokine levels at 3 years postpartum, comparing women who never breastfed, whose breastfeeding was curtailed, or who breastfed
successfully:* predicted values† from linear regression models
n Never breastfed
Curtailed
breastfeeding,
problems with
milk supply*
Curtailed
breastfeeding,
no problems
with milk supply*
Successful
breastfeeding* P‡
Leptin (ng/mL) (n) 69 67 45 383
Unadjusted 564 11.2 (9.7–12.6)§ 7.9 (6.4–9.3) 9.0 (7.2–10.8) 8.7 (8.1–9.3) ,0.01
Multivariable adjusted 564 8.9 (7.6–10.1)§ 6.8 (5.6–8.1) 7.5 (6.0–9.0) 8.0 (7.1–8.8)§ 0.05
Adiponectin (mg/mL) (n) 70 67 45 384
Unadjusted 566 19.0 (17.0–21.0) 21.3 (19.2–23.3) 19.9 (17.4–22.4) 20.2 (19.4–21.1) 0.50
Multivariable adjusted 566 20.9 (18.6–23.3) 22.7 (20.3–25.1) 21.3 (18.5–24.1) 21.2 (19.7–22.8) 0.58
Ghrelin (pg/mL) (n) 17 23 20 117
Unadjusted 177 574.7 (427.9–721.5)‖ 718.9 (592.7–845.1) 682.2 (546.8–817.5) 775.7 (719.8–831.6) 0.07
Multivariable adjusted 177 721.8 (566.6–877.1) 774.0 (645.4–902.5) 713.4 (568.5–858.3) 824.4 (736.3–912.4) 0.18
PYY (pg/mL) (n)¶ 17 23 21 116
Unadjusted 177 53.4 (45.7–62.4) 57.5 (50.4–65.7) 56.5 (49.2–65.0) 60.2 (56.7–63.9) 0.48
Multivariable adjusted 177 52.3 (43.0–63.5) 57.0 (48.5–67.0) 58.8 (49.1–70.3) 60.9 (54.5–68.0) 0.33
Data from 570 participants in Project Viva who presented for follow-up at 3 years postpartum without an intervening birth. *We used data on
mothers’ intended duration of breastfeeding, as reported at 28 weeks of pregnancy to deﬁne curtailed breastfeeding as either 1) weaning prior
to 3 months among women who planned to breastfeed for more than 3 months or 2) introduction of formula prior to 3 months among women
who planned to breastfeed exclusively for at least 3 months. At the 6-month interview, mothers who had weaned or were supplementing
identiﬁed reasons for introducing formula or weaning from a structured list. We classiﬁed women as having problems with milk supply if they
endorsed any of the following: “I wasn’t producing enough breast milk to satisfy my baby,”“ I had difﬁculty or didn’t like pumping breast milk,”
or “My baby was not gaining enough weight with breastfeeding.”† For the multivariate-adjusted model, data presented are mean predicted
values for a participant with a prepregnancy BMI of 25.1 kg/m
2, the mean for the study population, modeled using a three-knot quadratic spline
model for BMI. This participant was a white woman aged 35–40 years, has two children, has no parental history of diabetes, had normal
glucose tolerance, is a nonsmoker, and gained 15 kg during the index pregnancy. ‡Partial F test P values for differences among categories.
§P , 0.05 vs. curtailed breastfeeding problems with supply group. ||P , 0.05, vs. successful breastfeeding group. ¶Results presented for PYY
are geometric means. Because this outcome was not normally distributed, it was modeled on the log scale. Predicted values are exponentiated
for presentation to improve interpretability.
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